DR. LLOYD PETER HASKELL, MD
Osteopathic Medicine at Ups N Downs Ct, Flemington, NJ
License number
New Jersey 136002
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
4 N Ups N Downs Ct, Flemington, NJ 08822
37 New Dorp Plz N, Staten Island, NY 10306
37 New Dorp Plz N, Staten Island, NY 10306
Phone
(908) 782-0493
(908) 672-4913
(908) 672-4913
Personal information
See more information about LLOYD PETER HASKELL at radaris.comName
Address
Phone
26 Pleasant Ave, Walden, NY 12586
4 Ups N Downs Ct, Flemington, NJ 08822
26 Pleasant Ave APT 28, Walden, NY 12586
220 3Rd St, Wallkill, NY 12589
Flemington, NJ
Professional information
Dr. Lloyd P Haskell, Flemington NJ - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Nephrology
Address:
4 Ups N Downs Ct, Flemington 08822
(908) 782-0493 (Phone)
(908) 782-0493 (Phone)
Certifications:
Critical Care Medicine, 1989, Internal Medicine, 1980, Nephrology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York Medical College
Graduated: 1977
Beth Israel Medical Center-Petrie Campus
New York University
New York Medical College
Graduated: 1977
Beth Israel Medical Center-Petrie Campus
New York University
Combination Therapy Comprising Angiotensin Converting Enzyme Inhibitors And Vasopressin Receptor Antagonists
US Patent:
2009011, May 7, 2009
Filed:
Nov 5, 2008
Appl. No.:
12/265098
Inventors:
Bruce Damiano - Warrington PA, US
Lloyd Haskell - Flemington NJ, US
Umesh Shukla - Belle Mead NJ, US
Lloyd Haskell - Flemington NJ, US
Umesh Shukla - Belle Mead NJ, US
International Classification:
A61K 31/55, A61P 9/04, A61P 9/12, A61P 9/10, A61P 25/00
US Classification:
51421202
Abstract:
The present invention relates to certain pharmaceutical compositions containing at least one vasopressin receptor antagonist and at least one angiotensin converting enzyme (ACE) inhibitor and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of vasopressin and/or angiotensin converting enzyme mediated disorders.
Combination Therapy Comprising Angiotensin Receptor Blockers And Vasopressin Receptor Antagonists
US Patent:
2010009, Apr 15, 2010
Filed:
Oct 8, 2009
Appl. No.:
12/575869
Inventors:
Bruce Damiano - Lansdale PA, US
Lloyd Haskell - Flemington NJ, US
Umesh Shukla - Belle Mead NJ, US
Lloyd Haskell - Flemington NJ, US
Umesh Shukla - Belle Mead NJ, US
International Classification:
A61K 31/55, A61P 13/00
US Classification:
51421202
Abstract:
The present invention relates to certain pharmaceutical compositions containing at least one vasopressin receptor antagonist and at least one angiotensin receptor blocker (ARB) and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of vasopressin and/or angiotensin-mediated disorders.
Oxazolidinones For The Treatment And/Or Prophylaxis Of Heart Failure
US Patent:
2011000, Jan 6, 2011
Filed:
Dec 3, 2008
Appl. No.:
12/746661
Inventors:
Harald Kallabis - Koln, DE
Wolfgang Thielemann - Wuppertal, DE
Elisabeth Perzborn - Wuppertal, DE
Susanne Röhrig - Hilden, DE
Dagmar Kubitza - Ratingen, DE
Theodore Spiro - Pennington NJ, US
Lloyd Haskell - Flemington NJ, US
Jeet Mahal - San Francisco CA, US
Wolfgang Thielemann - Wuppertal, DE
Elisabeth Perzborn - Wuppertal, DE
Susanne Röhrig - Hilden, DE
Dagmar Kubitza - Ratingen, DE
Theodore Spiro - Pennington NJ, US
Lloyd Haskell - Flemington NJ, US
Jeet Mahal - San Francisco CA, US
International Classification:
A61K 31/5377, A61P 9/00, A61P 7/02
US Classification:
5142308
Abstract:
The present invention relates to the use of selective inhibitors of coagulation factor Xa, in particular of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure as well as their use for the preparation of pharmaceutical drugs for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure.